All the news Showing 10 of 25 articles from: Antiviral therapyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Treatment for chronic hepatitis B linked to increased rates of colorectal and cervical cancer EASL press release / 15 April 2016 ContraVir's CMX157 Outperforms Gilead's Tenofovir AF (TAF) Against Hepatitis B Virus in Independent Head-to-Head In-Vitro Study ContraVir press release / 30 March 2016 J&J signs deal with Chinese company for hepatitis B drug Reuters / 08 January 2016 Gilead Announces Top-Line Results From Two Phase 3 Studies Evaluating Tenofovir Alafenamide (TAF) for Patients With Chronic Hepatitis B Infection Gilead press release / 05 January 2016 Cancer drug shows promise as cure for hepatitis B Science Daily / 21 April 2015 Arrowhead initiates phase 2b trial for potential HBV drug Healio Hepatology / 14 April 2015 WHO issues its first hepatitis B treatment guidelines World Health Organization / 12 March 2015 FDA places Arrowhead Hepatitis B drug on partial hold, shares plunge Reuters / 13 January 2015 Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company Tekmira press release / 13 January 2015 Medivir and Daewoong pull plug on hepatitis B drug PharmaTimes / 06 September 2013 ← Prev123Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive